Cresanto Global Approves Material Related Party Transactions at Board Meeting
Cresanto Global Ltd, formerly known as Raymed Labs Limited, announced that its Board of Directors considered and approved several matters relating to Material Related Party Transactions (MSRT) during a meeting held on 31 July 2026.The company's board addressed the approval of MSRTs under relevant corporate regulations. The meeting commenced at 02:15 p.m. and concluded at 02:30 p.m.
Details of Related Party Transactions
The approved transactions involve a group of designated promoter and non-executive directors. These individuals are defined as related parties, holding a significant influence over the reporting entity. The proposed business activities encompass various arrangements such as contracts, agreements, loan transactions, or extending corporate guarantees in lieu of loans taken by the company. The nature of these transactions is specified as being within the normal course of business, with terms and conditions generally aligned with those prevalent across their respective industry segments.The maximum monetary value for these proposed contracts and arrangements has been established for each related party. These transactions are set to run from the conclusion of the Annual General Meeting (AGM) in FY 26-27 until the AGM scheduled for FY 27-28.
Key details regarding the related parties and their associated transactional limits are provided below:
| Related Party | Designation | Maximum Transaction Limit |
|---|---|---|
| Urmila Hansraj Sharma | Promoter & Non-Executive Director | Rs. 5 crores |
| Hitesh Bajoria | Promoter & Non-Executive Director | Rs. 5 crores |
| Nishant Nathmal Bajaj | Promoter & Non-Executive Director | Rs. 5 crores |
| Prashant Nathmal Bajaj | Promoter & Managing Director | Rs. 5 crores |
Stock Price Movement
Cresanto Global Ltd closed trading on Monday at ₹4.88, settling completely flat with zero percentage change. The shares remained locked at this price point throughout the day, reflecting a perfect range from ₹4.88 to ₹4.88.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.